SEC Form 4 · accession 0001127602-17-033796

HAEMONETICS CORP · HAE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 1, 2017

Accepted (ET)

Dec 4, 2017 · 4:14 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000313143

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Dec 1, 2017	S	100	$57.225	D	31,663	D
Common Stock	Dec 1, 2017	S	18	$57.18	D	31,763	D
Common Stock	Dec 1, 2017	S	200	$57.17	D	31,781	D
Common Stock	Dec 1, 2017	S	100	$57.15	D	31,981	D
Common Stock	Dec 1, 2017	S	100	$57.14	D	32,081	D
Common Stock	Dec 1, 2017	S	100	$57.13	D	32,181	D
Common Stock	Dec 1, 2017	S	100	$57.125	D	32,281	D
Common Stock	Dec 1, 2017	M	7,118	$34.405	A	38,781	D
Common Stock	Dec 1, 2017	S	300	$57.00	D	38,481	D
Common Stock	Dec 1, 2017	S	100	$57.005	D	38,381	D
Common Stock	Dec 1, 2017	S	100	$57.007	D	38,281	D
Common Stock	Dec 1, 2017	S	100	$57.015	D	38,181	D
Common Stock	Dec 1, 2017	S	91	$57.02	D	38,090	D
Common Stock	Dec 1, 2017	S	100	$57.03	D	37,990	D
Common Stock	Dec 1, 2017	S	9	$57.05	D	37,981	D
Common Stock	Dec 1, 2017	S	4,100	$57.055	D	33,881	D
Common Stock	Dec 1, 2017	S	200	$57.06	D	33,681	D
Common Stock	Dec 1, 2017	S	760	$57.07	D	32,921	D
Common Stock	Dec 1, 2017	S	100	$57.0749	D	32,821	D
Common Stock	Dec 1, 2017	S	200	$57.08	D	32,621	D
Common Stock	Dec 1, 2017	S	200	$57.09	D	32,421	D
Common Stock	Dec 1, 2017	S	40	$57.10	D	32,381	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-qualified Stock Option (Right to Buy)^F1	$34.405	Dec 1, 2017	M	7,118	D	Jul 21, 2012	Jul 21, 2018	Common Stock	7,118	0	D

F1Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.